サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386268

レーベル先天黒内障市場レポート：2030年までの動向、予測、競合分析

Leber Congenital Amaurosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

レーベル先天黒内障市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

レーベル先天黒内障の動向と予測

世界のレーベル先天黒内障市場は、2024年から2030年までのCAGRが4.2%で、2030年までに推定12億6,000万米ドルに達すると予測されます。この市場の主な促進要因は、rpe65遺伝子を介した網膜疾患の罹患率の増加、世界各国の政府によるLCA研究費の増加、製薬会社による投資の増加です。世界のレーベル先天黒内障（LPA）市場の将来は、病院、専門クリニック、外来手術センター、在宅ヘルスケア市場におけるビジネスチャンスで有望視されています。

レーベル先天黒内障市場の洞察

Lucintelの予測では、LCAの効果的な治療に対するアンメットニーズの高まりから、予測期間中に治療が高い成長を遂げる見込みです。

この市場において、病院はLCAの診断と治療に必要な設備と専門知識を提供するため、最大のセグメントであり続けると思われます。

北米はヘルスケアインフラが発達しているため、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のレーベル先天黒内障市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のレーベル先天黒内障市場動向（2018-2023）と予測（2024-2030）
  • タイプ別の世界のレーベル先天黒内障市場
    • 治療
    • 診断
  • 疾患タイプ別の世界のレーベル先天黒内障市場
    • 幼児タイプ
    • 若年性タイプ
    • その他
  • 最終用途別の世界のレーベル先天黒内障市場
    • 病院
    • 専門クリニック
    • 外来手術センター
    • 在宅ヘルスケア
    • その他
  • 流通チャネル別の世界のレーベル先天黒内障市場
    • 直接入札
    • 小売販売

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のレーベル先天黒内障市場
  • 北米のレーベル先天黒内障市場
  • 欧州のレーベル先天黒内障市場
  • アジア太平洋レーベル先天黒内障市場
  • その他地域レーベル先天黒内障市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • タイプ別の世界のレーベル先天黒内障市場の成長機会
    • 疾患タイプ別の世界のレーベル先天黒内障市場の成長機会
    • 最終用途別の世界のレーベル先天黒内障市場の成長機会
    • 流通チャネル別の世界のレーベル先天黒内障市場の成長機会
    • 地域別の世界のレーベル先天黒内障市場の成長機会
  • 世界のレーベル先天黒内障市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のレーベル先天黒内障市場の能力拡大
    • 世界のレーベル先天黒内障市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Invitae Corporation
  • Spark Therapeutics
  • LKC Technologies
  • CENTOGENE
  • Optos
  • Metrovision
  • Blue Print Genetics Oy
  • CD Genomics
  • ProQR Therapeutics
  • OCUGEN
目次

Leber Congenital Amaurosis Trends and Forecast

The future of the global leber congenital amaurosis (LPA) market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets. The global leber congenital amaurosis market is expected to reach an estimated $1.26 billion by 2030 with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are growing incidence of rpe65 gene-mediated in retinal diseases, governments around the world are increasing funding for research into LCA, and rising investment from pharmaceutical companies.

A more than 150-page report is developed to help in your business decisions.

Leber Congenital Amaurosis by Segment

The study includes a forecast for the global leber congenital amaurosis by type, disease type, end use, distribution channel, and region.

Leber Congenital Amaurosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Therapy
  • Diagnosis

Leber Congenital Amaurosis Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Infantile Type
  • Juvenile Type
  • Others

Leber Congenital Amaurosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Healthcare
  • Others

Leber Congenital Amaurosis Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Direct Tender
  • Retail Sales

Leber Congenital Amaurosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Leber Congenital Amaurosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies leber congenital amaurosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the leber congenital amaurosis companies profiled in this report include-

  • Invitae Corporation
  • Spark Therapeutics
  • LKC Technologies
  • CENTOGENE
  • Optos
  • Metrovision
  • Blue Print Genetics Oy
  • CD Genomics
  • ProQR Therapeutics
  • OCUGEN

Leber Congenital Amaurosis Market Insights

Lucintel forecasts that therapy is expected to witness higher growth over the forecast period due to growing unmet need for effective treatments for LCA.

Within this market, hospital will remain the largest segment as it provides necessary equipment and expertise to diagnose and treat LCA.

North America will remain the largest region over the forecast period due to a well-developed healthcare infrastructure.

Features of the Global Leber Congenital Amaurosis Market

Market Size Estimates: Leber congenital amaurosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Leber congenital amaurosis market size by various segments, such as by type, disease type, end use, distribution channel, and region in terms of ($B).

Regional Analysis: Leber congenital amaurosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, disease types, end uses, distribution channels, and regions for the leber congenital amaurosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the leber congenital amaurosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the leber congenital amaurosis market size?

Answer: The global leber congenital amaurosis market is expected to reach an estimated $1.26 billion by 2030.

Q.2 What is the growth forecast for leber congenital amaurosis market?

Answer: The global leber congenital amaurosis market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the leber congenital amaurosis market?

Answer: The major drivers for this market are growing incidence of rpe65 gene-mediated in retinal diseases, governments around the world are increasing funding for research into LCA, and rising investment from pharmaceutical companies.

Q4. What are the major segments for leber congenital amaurosis market?

Answer: The future of the leber congenital amaurosis market (LCA) looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets.

Q5. Who are the key leber congenital amaurosis market companies?

Answer: Some of the key leber congenital amaurosis companies are as follows:

  • Invitae Corporation
  • Spark Therapeutics
  • LKC Technologies
  • CENTOGENE
  • Optos
  • Metrovision
  • Blue Print Genetics Oy
  • CD Genomics
  • ProQR Therapeutics
  • OCUGEN

Q6. Which leber congenital amaurosis market segment will be the largest in future?

Answer: Lucintel forecasts that therapy is expected to witness higher growth over the forecast period due to growing unmet need for effective treatments for LCA.

Q7. In leber congenital amaurosis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to a well-developed healthcare infrastructure.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the leber congenital amaurosis market by type (therapy and diagnosis), disease type (infantile type, juvenile type , and others), end use (hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others), distribution channel (direct tender and retail sales), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Leber Congenital Amaurosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Leber Congenital Amaurosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Leber Congenital Amaurosis Market by Type
    • 3.3.1: Therapy
    • 3.3.2: Diagnosis
  • 3.4: Global Leber Congenital Amaurosis Market by Disease Type
    • 3.4.1: Infantile Type
    • 3.4.2: Juvenile Type
    • 3.4.3: Others
  • 3.5: Global Leber Congenital Amaurosis Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Home Healthcare
    • 3.5.5: Others
  • 3.6: Global Leber Congenital Amaurosis Market by Distribution Channel
    • 3.6.1: Direct Tender
    • 3.6.2: Retail Sales

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Leber Congenital Amaurosis Market by Region
  • 4.2: North American Leber Congenital Amaurosis Market
    • 4.2.2: North American Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.3: European Leber Congenital Amaurosis Market
    • 4.3.1: European Leber Congenital Amaurosis Market by Type: Therapy and Diagnosis
    • 4.3.2: European Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.4: APAC Leber Congenital Amaurosis Market
    • 4.4.1: APAC Leber Congenital Amaurosis Market by Type: Therapy and Diagnosis
    • 4.4.2: APAC Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.5: ROW Leber Congenital Amaurosis Market
    • 4.5.1: ROW Leber Congenital Amaurosis Market by Type: Therapy and Diagnosis
    • 4.5.2: ROW Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Type
    • 6.1.2: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Leber Congenital Amaurosis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Region
  • 6.2: Emerging Trends in the Global Leber Congenital Amaurosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Leber Congenital Amaurosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Leber Congenital Amaurosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Invitae Corporation
  • 7.2: Spark Therapeutics
  • 7.3: LKC Technologies
  • 7.4: CENTOGENE
  • 7.5: Optos
  • 7.6: Metrovision
  • 7.7: Blue Print Genetics Oy
  • 7.8: CD Genomics
  • 7.9: ProQR Therapeutics
  • 7.10: OCUGEN